Research Award Details

2018 - Angela S.M. Kuo Memorial Award

Health Related Quality of Life Outcomes in Patients with Early-Onset Scoliosis


Grant Recipient: Brandon Ramo, MD

Co-Investigators: Matthew Oetgen, MD

Institution:
Growing Spine Foundation
Presentations & Publications:
Presentations:
Two abstracts (one for aim 1 and one for aim 2 findings) were submitted to SRS/IMAST but were not accepted.  Two abstracts were presented at ICEOS 2019 and one abstract was presented at POSNA 2020.
  1. Brandon Ramo, Anna McClung, Chan-Hee Jo, Burt Yazsay, Lindsay Andras, Matt Oetgen, Pediatric Spine Study Group.  Validation of the Early Onset Scoliosis Questionnaire (EOSQ) as applied to the Classification of Early Onset Scoliosis (C-EOS) Etiology Designation Before Scoliosis Treatment.   International Congress of Early Onset Scoliosis, 13th Annual Meeting.  Nov 21-22, 2019.  Atlanta, GA.
  2. Brandon Ramo, Anna McClung, Chan-Hee Jo, Paul Sponseller, Firoz Miyanji, Matt Oetgen, Pediatric Spine Study Group.  The Effect of Medical Comorbidities on subdomain scores of the Early Onset Scoliosis Questionnaire (EOSQ) Before Treatment.  International Congress of Early Onset Scoliosis, 13th Annual Meeting.  Nov 21-22, 2019.  Atlanta, GA.
  3. Brandon Ramo, Anna McClung, Chan-Hee Jo, Burt Yazsay, Lindsay Andras, Matt Oetgen, Pediatric Spine Study Group.  Validation of the Early Onset Scoliosis Questionnaire (EOSQ) as applied to the Classification of Early Onset Scoliosis (C-EOS) Etiology Designation Before Scoliosis Treatment.   POSNA Annual Meeting. May 13-16, 2020. San Diego CA.
 
Publications:
Manuscript has been provisionally accepted by JBJS as of 8/31/2020 with final acceptance pending at this time.  If not accepted for final publication, will be submitted elsewhere, likely Spine Deformity.
  1. Brandon Ramo, Anna McClung, Chan-Hee Jo, Burt Yaszay, James O Sanders, Matthew E. Oetgen, PSSG. The Effect of Disease Etiology, Radiographic Deformity Severity, and Medical Comorbidities on Baseline Patient Reported Health Measures in Children with Early Onset Scoliosis. 
Additional Information:

Work continues on Aims 3 and 4 with statistical analysis nearly complete and hope to submit results of treatment-based outcomes in 2021.